Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23382472

Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2013 Mar 20
First author
Hurvitz SA

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 Aug 10;31(23):2977
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Future Oncol. 2013 Jul;9(7):955-7. doi: 10.2217/fon.13.74.
    note
    Source null
    related pmid
    23837759
    relationship
    Comment in

Authors and identifiers

  1. name
    Hurvitz SA
    type
    Author
  2. name
    Dirix L
    type
    Author
  3. name
    Kocsis J
    type
    Author
  4. name
    Bianchi GV
    type
    Author
  5. name
    Lu J
    type
    Author
  6. name
    Vinholes J
    type
    Author
  7. name
    Guardino E
    type
    Author
  8. name
    Song C
    type
    Author
  9. name
    Tong B
    type
    Author
  10. name
    Ng V
    type
    Author
  11. name
    Chu YW
    type
    Author
  12. name
    Perez EA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hurvitz SA
    type
    Author
  2. name
    Dirix L
    type
    Author
  3. name
    Kocsis J
    type
    Author
  4. name
    Bianchi GV
    type
    Author
  5. name
    Lu J
    type
    Author
  6. name
    Vinholes J
    type
    Author
  7. name
    Guardino E
    type
    Author
  8. name
    Song C
    type
    Author
  9. name
    Tong B
    type
    Author
  10. name
    Ng V
    type
    Author
  11. name
    Chu YW
    type
    Author
  12. name
    Perez EA
    type
    Author
bibliography ids
  1. nci-bib-6de21438a5f20283708a9632
book metadata
content sha256
6bf67dd1fbe11fd9989b68512df3f29ffb1ba213917bf0991b5f6c59ef40e046
document type
citation
dois
  1. 10.1200/JCO.2012.44.9694
electronic publication date
display
2013 Feb 4
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23382472
immutable id
pubmed:23382472@6bf67dd1fbe11fd9989b68512df3f29ffb1ba213917bf0991b5f6c59ef40e046
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
9
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1157-63
volume
31
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 Aug 10;31(23):2977
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Future Oncol. 2013 Jul;9(7):955-7. doi: 10.2217/fon.13.74.
    note
    Source null
    related pmid
    23837759
    relationship
    Comment in
outcomes validated
false
pmid
23382472
provenance
batch id
99e008dabc339d38fd44
provider
NCBI PubMed ESummary
record sha256
ad561f0bfeda5f86d3d5bfbfc59408e32e080782b7811d2694f463e1a61d9d33
response sha256
804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
retrieved at
2026-09-09T23:46:55.094762+00:00
publication date
display
2013 Mar 20
precision
day
year
2013
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23382472/
title
Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Preserved source evidence · Not medical advice